EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation

Zhongqin Tang, Ying Wang, Ziling Yang, Juan Chen, Shuqi Cai, Zhiguo Zhang, Jianye Wang, Zhaolian Wei

Regenerative Therapy · 2025-12 · 30 · 1052-1061

DOI: 10.1016/j.reth.2025.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Therapy, 2025-12. Verfasst von Zhongqin Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei, 230022, Anhui, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anhui Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Stem cell therapy is increasingly advancing towards clinical applications, with cryopreservation playing a critical role in cell transplantation. Previous studies have demonstrated that hydrogel microcapsules can enhance cell survival during cryopreservation. However, most research has focused on rapid freezing techniques or cryopreservation with high-concentration dimethyl sulfoxide (DMSO). This study aims to investigate the effects of hydrogel microcapsules on the viability, phenotype, and functionality of mesenchymal stem cells (MSCs) following cryopreservation with low-concentration DMSO. The objective is to develop a safer cryopreservation strategy for clinical stem cell applications.

Methods

In this study, We utilized five concentrations of DMSO (0 %, 1.0 %, 2.5 %, 5.0 %, 10.0 %(v/v)) to cryopreserve fabricated MSCs-laden microcapsules. We analyzed the effects of varying DMSO concentrations on the viability of microencapsulated MSCs, and the impact of hydrogel microcapsules on MSCs quality after cryopreservation with 2.5 % DMSO was investigated, including cell viability, morphology, phenotype, the expression of stemness-related genes and multidirectional differentiation potential.

Results

The results showed that when the DMSO concentration was reduced to 2.5 %, cell viability reached the minimum requirement (70 %) for clinical treatment, and it was demonstrated that, under low-concentration DMSO cryopreservation, the microencapsulation technique did not alter the stem cell phenotype and differentiation potential, and improved stem cell viability.

Conclusions

Hydrogel microencapsulation technology can reduce the concentration of DMSO required in stem cell cryopreservation and mitigate cryoinjury to cells. The cryopreservation of three dimensional (3D) cell constructs based on cell-biomaterials provides a highly promising new strategy for efficient stem cell storage and clinical applications.

Schlagwörter

Stichwörter der Autor:innen

AlginateCryopreservationDMSOHydrogelMesenchymal stem cellsMicrocapsule encapsulation

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei, 230022, Anhui, China.
  • Anhui Province Key Laboratory of Reproductive Health and Genetics, Anhui Medical University, No 81 Meishan Road, Hefei, 230032, Anhui, China.
  • NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), No 81 Meishan Road, Hefei, 230032, Anhui, China.
  • Innovation Research Institute of Engineering Medicine and Medical Equipment, Anhui Medical University, No 81 Meishan Road, Hefei, 230032, Anhui, China.

Förderung

  • Anhui Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Tang, Z., Wang, Y., Yang, Z., Chen, J., Cai, S., Zhang, Z., Wang, J., & Wei, Z. (2025). Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation. Regenerative Therapy, 30, 1052-1061. https://doi.org/10.1016/j.reth.2025.10.016

Vancouver

Tang Z, Wang Y, Yang Z, Chen J, Cai S, Zhang Z, et al. Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation. Regenerative Therapy. 2025;30:1052-1061. doi:10.1016/j.reth.2025.10.016

BibTeX
@article{Tang2025,
  author = {Tang, Zhongqin and Wang, Ying and Yang, Ziling and Chen, Juan and Cai, Shuqi and Zhang, Zhiguo and Wang, Jianye and Wei, Zhaolian},
  title = {Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation},
  journal = {Regenerative Therapy},
  year = {2025},
  volume = {30},
  pages = {1052--1061},
  doi = {10.1016/j.reth.2025.10.016}
}
Kostenlos starten →